Cempra, Inc. (CEMP)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
25.21+0.61 (+2.48%)
At close: 4:00 PM EDT
People also watch:
TTPHESPRPTLACLVSKITE
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Open24.59
Prev Close24.60
Bid22.00 x 500
Ask25.42 x 700
Day's Range24.51 - 25.41
52wk Range14.03 - 34.79
1y Target EstN/A
Market Cap1.31B
P/E Ratio (ttm)-11.30
Beta1.51
Volume875,600
Avg Vol (3m)772,950
Dividend & YieldN/A (N/A)
Earnings DateN/A
Trade prices are not sourced from all markets
  • Capital Cube16 days ago

    ETF’s with exposure to Cempra, Inc. : September 9, 2016

    Categories: ETFs Yahoo Finance Click here to see latest analysis ETF’s with exposure to Cempra, Inc. Here are 5 ETF’s with the largest exposure to CEMP-US. Comparing the performance and risk of Cempra, Inc. with the ETF’s that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • GlobeNewswire25 days ago

    Cempra to Present at Three Upcoming Investor Conferences

    CHAPEL HILL, N.C., Sept. 01, 2016-- Cempra, Inc., a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the treatment of bacterial infectious diseases, ...

  • GlobeNewswire27 days ago

    Cempra to Present Solithromycin at FDA Antimicrobial Drugs Advisory Committee Meeting on November 4, 2016

    CHAPEL HILL, N.C., Aug. 30, 2016-- Cempra, Inc., a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the treatment of bacterial infectious diseases, ...